Introduction
The initially promising potential of adenoviruses as vectors for delivering genes into the central nervous system (CNS) for treatment of neurological disorders has been diminished by limitations in three main areas. Firstly, transgene expression in the CNS falls significantly from initial levels within days to weeks following injection, although it is thereafter maintained for several months. [1] [2] [3] [4] [5] [6] [7] Adenoviral vectors are toxic to neurons and glia in vitro and in vivo at high multiplicities of infection, [8] [9] [10] [11] [12] [13] and they induce an immune response in the CNS, composed of a T cell-independent followed by a T cell-mediated response. 4, 12 Despite these limitations, adenoviral vectors have been effective in experimental models of gene therapy in the CNS, most of which have aimed to protect or restore lost function to neuronal populations 7, 10, [14] [15] [16] [17] or to treat CNS tumours. 13, 18, 19 The spinal cord white matter is another major site in the CNS in which in vivo gene delivery has potential therapeutic application, particularly in experimental models for axonal regeneration [20] [21] [22] [23] [24] and remyelination. 25, 26 The focus of most studies using adenoviral vectors in the CNS has been the level and longevity of transgene expression and the immune response to the virus, with some attention to adenovirus-mediated tissue damage, usually observed as necrosis. [8] [9] [10] 12, 13, 27 The aim of the current study was to evaluate not only adenovirusmediated transgene expression and immunogenicity in spinal cord white matter, but also to assess the severity and specificity of adenovirus-mediated tissue damage by examining resin-embedded tissue in order further to assess the suitability of adenoviral vectors for gene delivery at this site.
Results
Experiment 1: The number of cells expressing ␤-galactosidase is determined by the number of adenovirus p.f.u. injected Twelve outbred Sprague-Dawley rats were randomly divided into four groups, and each group (n = 3) received injections of 10 4 , 10 5 , 10 6 or 10 7 p.f.u. ␤-galactosidase (␤gal)-expressing adenovirus into the dorsal funiculus of the spinal cord. After 2 days rats were killed and ␤gal expression was assessed. ␤Gal-expressing cells were detected in all except one animal, which was from the group injected with 10 6 p.f.u. This animal was excluded from the analysis as it was presumed that the injection technique was faulty. The use of the nuclear targeted ␤gal construct enabled quantification of ␤gal-expressing cells. The number of ␤gal-expressing cells was found to correlate significantly with the number of adenovirus p.f.u. injected ( Figure 1a ) (Spearman's r = 1, P = 0.042). There was no significant correlation between the longitudinal spread of ␤gal-expressing cells (Figure 1b ) and the number of p.f.u. injected (Spearman's r = 0.8, P = 0.167). ␤gal expression was detected in cell nuclei, but near the injection site cell processes were also ␤gal positive ( Figure  2C ). The intensity of expression in individual cells appeared qualitatively greater in the higher dose groups and at the injection site (Figure 2A-D) . For animals receiving 10 7 and 10 6 p.f.u., some 75 m sections near the injection site contained areas within the dorsal funiculus which were devoid of ␤gal-expressing cells, and contained tissue debris which stained faintly with carminic acid, a change interpreted as necrosis (Figure 2A, B) . Necrotic tissue was not observed in animals in the two lower dose groups.
Experiment 2: Injection of high titres of adenovirus results in axon degeneration, demyelination and astrocyte loss The severity of damage to spinal cord white matter caused by the injection of four different titres (n = 3 per group) of adenovirus was assessed. Adenovirus was injected into adult female PVG rats and 30 days later tissue was embedded in resin for detailed histological examination. The amount of damage caused by the injection procedure was determined by examination of sections from buffer-injected animals (n = 3). In bufferinjected animals Wallerian degeneration of small numbers of axons was observed, indicating that the injection procedure caused some axon damage. No demyelination or remyelination was observed ( Figure 3A, B) . In animals injected with 10 4 and 10 5 p.f.u. Wallerian degeneration of small numbers of axons was observed. In addition, focal areas of oligodendrocyte remyelination, indicating a previous episode of demyelination, were seen in one animal from each group (Figure 3C, D) . In all animals injected with 10 6 and 10 7 p.f.u. there was a large central area of tissue damage in the dorsal funiculus which contained debris-filled macrophages, together with large numbers of axons undergoing Wallerian degeneration ( Figure 3F ). In addition, three distinct types of pathology were observed. In two animals oligodendrocyte remyelination was observed in the damaged area ( Figure 3F ). In three animals there was an increased amount of extracellular space in the centre of the lesion, and in this area axons had been remyelinated by Schwann cells (Figure 3G ), indicating that demyelination accompanied by astrocyte loss had occurred, allowing entry of Schwann cells into the CNS from the peripheral nervous system. 28, 29 In these animals focal areas of oligodendrocyte remyelination were seen, particularly at the margins of the lesion. In one animal the lesioned area contained large numbers of unmyelinated axons together with accumulations of myelin debris, but very little remyelination ( Figure 3H ). Experiment 3: Injection of low titres of adenovirus results in a minimal immune response in the spinal cord and brain, and long-term maintenance of transgene expression On the basis of the observation that injection of 10 5 p.f.u. into the spinal cord white matter gave maximal ␤gal expression with minimal tissue damage, we examined the immune response in the spinal cord of female PVG rats to this concentration of adenovirus at various timepoints up to 72 days, compared with the immune response to injection of buffer alone. In adenovirus-and buffer-injected animals both the intensity and specificity of staining of all markers were the same (summarised in Table 1 ). Weak immunoreactivity for major histocompatibility complex (MHC) class I, MHC class II, CR3 (complement receptor 3) and LCA (leucocyte common antigen) was observed at all time-points up to 72 days ( Figure 4A In order to determine whether this lack of inflammation was peculiar to injection of adenovirus into the spinal cord, the same number of adenovirus p.f.u. was injected into the caudate nucleus, the site of adenovirus injection in a previous immunological survey. 5 In the caudate nucleus, there was a similar mild increase in intensity of expression of MHC class I, MHC class II, CR3 and LCA at the injection site at 2 and 7 days, which was reduced in intensity by 14 days, and had disappeared at 30 and 72 days days (Table 1 and Figure 4C ). A small number of OX-62 cells were observed at 3 days but at no other time-point. Again, there was no evidence of infiltration of ␣␤ T cells, B cells, NK cells or neutrophils at the injection site. ␤Gal-expressing cells were observed at all time-points (Figures 1d and 2F), and comparison of the number of ␤gal-expressing cells at early (2, 7 and 14 days) and late (30 and 72 days) time-points revealed no significant difference (P Ͼ 0.01) by the Mann-Whitney test.
Experiment 4: The intensity of the immune response to adenoviruses in the spinal cord is determined by both titre and rat strain In previous studies the intensity of the immune response of inbred rodent strains to various antigens has been shown to depend on genes linked to the major histocompatibility complex, 30 and has resulted in the classification of various rodent strains as 'high' or 'low' responders. In a previous study in which adenovirus was injected into the brain, 4 it was demonstrated that the immune response to adenovirus in the low responder PVG rat strain is much reduced compared with rats of the high responder AO strain. In order to determine whether the minimal inflammatory response observed in experiment 3 was due to injection of fewer adenovirus p.f.u. or strain differences, AO and PVG rats were injected with 10 7 p.f.u., and AO rats were injected with 10 5 p.f.u., and 
. (F, H) adenovirus into the dorsal funiculus of the spinal cord. Low magnification views of the dorsal funiculus (A, C, E) allow comparison of the areas of damage induced by each type of injection (white arrows). In buffer-injected animals the damaged area contains axons undergoing Wallerian degeneration (white arrows, B). In animals injected with 10 5 p.f.u. adenovirus, axons surrounded by thin myelin sheaths, indicating oligodendrocyte remyelination are present within the damaged area (white arrows, D). In animals injected with 10 6 or 10 7 p.f.u. three different types of pathology are identified: (F) predominantly oligodendrocyte remyelination (white arrows); (G) predominantly Schwann cell remyelination (black arrows), surrounded by abundant extracellular space; and (H) predominantly unmyelinated axons (black arrows). Schwann cell remyelinated axons are distinguished from oligodendrocyte remyelinated axons by the association of a cell body with each axon, and a thicker myelin sheath. Axons undergoing Wallerian degeneration are indicated in F by black arrows. A, C, E original magnification ×100; B, D, F-H original magnification ×600.
examined 7 and 14 days later, to coincide with the peak inflammatory response observed in previous studies. 4, 6, 12 The markers up-regulated in PVG rats injected with 10 5 p.f.u. (MHC class I, MHC class II, CR3 receptor and LCA) were also up-regulated in PVG and AO rats injected with 10 7 p.f.u., but the intensity of staining was greater (summarised in Table 2 and Figure 4D, F) . In addition, large numbers of T cells (R73, OX-35, OX-8, OX-39) and smaller numbers of ␥␦ Tcell/dendritic cells (OX-62), B cells (OX-35) and NK cells/neutrophils (3.2.3) were observed. In AO rats the increase in intensity of staining was more marked than in PVG rats, and at the 14 day time-point some markers (LCA, MHC I, MHC II, CR3 receptor, R73, OX-35, OX-39, OX-8, OX-62) were evident across the whole cross-section of the spinal cord of AO rats, whereas in PVG rats the inflammatory infiltrate was always confined to the dorsal funiculus ( Table 2 , compare Figure 4D with F). In both strains small numbers of B cells were present at the 14 day time-point. In AO rats injected with 10 5 p.f.u. the same markers were upregulated as those in PVG rats injected with 10 5 p.f.u., but the intensity of staining was greater (Table 2 and Figure 4E ). In addition, small numbers of OX-8 and OX-62 cells were observed at both time-points, and small numbers of 3.2.3-positive cells were present at the 7 day time-point.
Discussion
Axon degeneration and astrocyte loss are changes which would greatly interfere with studies aimed at assessing the effect of transgenes on axon or myelin regeneration in the spinal cord, and therefore injection of titres of virus which induce such changes (10 6 and 10 7 p.f.u.) would be unsuitable for such studies. Injection of 10 4 and 10 5 p.f.u. of virus also resulted in some tissue damage, however, this was far less severe than at higher titres, consisting of focal areas of demyelination together with low levels of axon degeneration. This degree of damage is unlikely to be problematic for studies assessing regeneration in the spinal cord white matter.
The exact mechanism of tissue damage observed in this study is not clear, but may have been due to a direct toxic effect of the virus or its transgene, 8, 9, 11, 12 or may have been mediated by the innate 4, 6 or the T cell immune response [4] [5] [6] 12 as a bystander effect of inflammation, 31, 32 or a combination of these. It is likely, however, that a significant proportion of damage was independent of the T cell immune response, since large areas of necrosis were evident in cryosectioned tissue as early as 2 days following injection ( Figure 3A, B) , which is before the T cell-mediated immune response reaches its peak. 4, 6, 12 Further, when recombinant adenovirus was injected into the spinal cord white matter of nude rats there was a similar degree and specificity of tissue damage to that observed in the current study (RJM Franklin, personal communication). It is of interest that the inflammatory infiltrate in animals injected with 10 5 p.f.u. virus was indistinguishable immunohistochemically from that of animals injected with buffer, consisting only of an increase in the number of OX-42 cells which expressed MHC class I and II. It was possible to demonstrate that the limited immune response was not specific to the lumbar spinal cord, since a similar mild response was observed when the same titre was injected into the brain, but due to a reduction in the titre of inoculated virus, as in PVG rats injected with a higher titre of adenovirus there was a more intense inflammatory response, composed of an infiltrate of cells not seen in the low titre group (T cells, B cells, OX-62-positive cells and NKR-P1-positive cells). Strain effects were also important since the immune response was always more intense in AO rats than in PVG rats receiving the same titre of virus. The absence of T cell infiltration in PVG rats injected with 10 5 p.f.u. suggests that injection of this low titre of virus failed to stimulate the adaptive arm of the immune response, resulting only in activation of macrophages and microglia at the injection site. The relative roles of the transgene product, ␤gal, and adenovirus-derived proteins in the induction of the immune response observed in the current study is not known. However, in previous studies it was shown that the immune response in the brain to first generation adenovirus expressing ␤gal was indistinguishable qualitatively 4, 33 and quantitatively 33 from that induced by an adenovirus in which no transgene was expressed. Therefore, adenoviral proteins alone are likely to be sufficiently immunogenic to induce the immune response observed in the current study, although ␤gal may also be the target of the immune response.
Quantification of transgene expression showed that the number of transgene-expressing cells correlated with the titre of injected adenovirus. In contrast to previous studies [1] [2] [3] [4] [5] [6] [7] the level of transgene expression did not decrease with time, at least up to the 72 day time-point, a finding which could prove to be useful in long-term studies of spinal cord regeneration. Presumably, the original level of transgene expression was maintained because cytopathic effects and/or the immunogenicity of the adenovirus were reduced at this lower titre. Whether this level of transduction of CNS cells will result in the production of sufficient levels of transgene to result in a therapeutic effect in models of CNS remains to be seen. However, the use of stronger promoter systems such as the tetracycline-responsive promoters, which have recently been shown to be effective in adenoviral vectors, 34 may overcome problems of low levels of transgene expression, providing that increased transgene expression does not enhance adenoviral toxicity.
In conclusion, it is possible to overcome most of the cytopathic and immunogenic properties of recombinant adenoviruses in spinal cord white matter by reducing the titre of injected virus and by using a low responder rat strain such as PVG as the recipient. When a titre of 10 5 p.f.u. is injected the immune response to the virus is indistinguishable from that induced by injection of buffer, moderate numbers of cells express the transgene, and tissue damage is restricted to a low level of axon degeneration and demyelination, which would not prohibit its use in experimental models of spinal cord regeneration.
Materials and methods
An E1-and E3-deleted adenovirus expressing ␤gal under the control of the Rous sarcoma virus promoter with a nuclear localisation signal 35 was prepared using standard protocols. Briefly, adenovirus was cultured on 293 cells, released from infected cells by three freeze-thaw cycles and sonication, purified on a cesium chloride gradient, dialysed against 10 mm Tris pH 7.5, 1 mm MgCl 2 , 135 mm NaCl buffer, then aliquoted, frozen and stored at −70°C. A titre of 1 × 10 10 p.f.u. per ml was obtained as determined by plaque assay on 293 cells. The same stock of virus was used for all injections.
Twelve Sprague-Dawley male, 39 PVG female and 15 AO female rats weighing approximately 200 g were purchased from Harlan, Bicester, UK and housed under barrier conditions at the Department of Human Anatomy.
Ten-fold serial dilutions of stock adenovirus were made, using 10 mm Tris pH 7.5, 1 mm MgCl 2 , 135 mm NaCl as diluent, the buffer against which stock virus was dialysed. Under general anaesthesia a volume of 1 l containing 10 4 , 10 5 , 10 6 or 10 7 p.f.u. adenovirus or buffer was injected into the spinal cord white matter. For brain injections 1 l containing 10 5 p.f.u. was injected into the right caudate nucleus (see below). For spinal cord injections rats were anaesthetised with halothane, and a dorsal laminectomy was performed on the first lumbar vertebra. The spinal column was immobilised by clamping the dorsal spinous process of the 13th thoracic vertebra, and the meninges were incised with a 22-gauge dental needle. Virus was loaded on to a Hamilton syringe to which a glass micropipette (tip diameter approximately 70 m) had been cemented and introduced into the dorsal funiculus to a depth of 1 mm with a micromanipulator. The virus was injected over a period of 2 min and the micropipette tip was left in place for a further 2 min before it was withdrawn. For injections into the caudate nucleus animals were anaesthetised with intraperitoneal hypnorm (0.2 mg/kg fentanyl citrate and 6 mg/kg fluanisone; Janssen, Oxford, UK), placed in a stereotactic injection apparatus (incisor bar set 2 mm below the interaural line) and injected at 3.5 mm lateral to bregma, 4.5 mm vertical from the dura. Virus was taken up into a 5 l glass micropipette (tip diameter approximately 70 m), injected over a period of 2 min and the micropipette tip was left in place for a further 5 min before it was withdrawn. Animals were divided into four experimental subgroups as follows.
Experiment 1: Quantification of expression of the transgene at 2 days Outbred Sprague-Dawley rats (n = 12) were used as it was considered that a genetically defined strain was not required for this aspect of the study. Rats were randomly divided into four groups, each group (n = 3) receiving injections into the dorsal funiculus of 10 4 , 10 Experiment 3: Immunohistochemical analysis of the immune response and quantification of ␤gal expression over a 72 day time-course in PVG rats On the basis of the findings of the above two studies, a time-course of the immune response in PVG rats to injection of 10 5 p.f.u. adenovirus in the brain and spinal cord was compared with the immune response to injection of buffer alone. For each study time-points included 2, 7, 14, 30 and 72 days, with three animals at each time-point. Animals were anaesthetised with halothane, killed by intraperitoneal pentobarbitone overdose and the vascular system was flushed via the left ventricle with phosphate buffer (0.2 m, pH 7.4). Brains or spinal cords were embedded in OCT, frozen on dry ice and stored at −20°C before sectioning on a cryostat at 10 m. Every 10th section was incubated in Xgal solution (see above) following fixation for 10 min in 100% ethanol at 4°C, in order to locate ␤gal-expressing cells. Immunostaining was carried out on sections deemed to be at the site of injection, as determined by either observation of the needle track, or the greatest number of ␤gal-expressing cells.
Control positive sections for each antibody were archived sections of rat brain which had received a xenograft of mouse brain into the caudate nucleus 7 days previously. 36 Immediately before immunostaining sections were fixed for 10 min in 100% ethanol at 4°C and endogenous peroxidase was blocked in 1.5% hydrogen peroxide. 1.5% normal rabbit serum was applied for 30 min, then primary antibody was applied for 1 h. Primary antibodies included OX-1 (leucocyte common antigen 37 ) In order to compare the number of ␤gal-expressing cells in PVG rats receiving injections of 10 5 p.f.u. into the spinal cord at early (2, 7 and 14 days) and late (30 and 72 days) time-points, one section at the injection site was taken from each animal and incubated in the Xgal reaction mixture at 37°C for 2 h. The number of ␤gal-expressing cells in each section was counted and early and late time-points were compared using the Mann-Whitney test.
Experiment 4: Immunohistochemical analysis of the immune response in PVG and AO rats to 10 5 and 10 7 p.f.u. adenovirus For examination of the immune response in a high responding rat strain, 10 7 or 10 5 p.f.u. adenovirus was injected into the dorsal funiculus of female AO rats (n = 12) and examined at 7 and 14 days (n = 3 per timepoint). For comparison of the immune response with a higher dose of adenovirus in PVG rats, 10 7 p.f.u. adenovirus was injected into the dorsal funiculus of the spinal cord of PVG rats and examined at 7 and 14 days (n = 3 per time-point). Tissue sections were immunostained with the antibodies as described in experiment 3.
